Monitoring Iron Levels in Hyperferritinemia

Recommended Monitoring Schedule

For patients with hyperferritinemia, iron studies should be monitored every 3 months to assess changes and guide management decisions, as recommended by the American Society of Hematology 1, 2, 3
Iron status should be assessed at diagnosis and at regular intervals thereafter, with a minimum of every 3 months for patients with hyperferritinemia 1, 2, 4
More frequent monitoring, such as monthly, is recommended for patients receiving iron chelation therapy or those with rapidly rising ferritin levels 1, 3
After intravenous iron administration, it is recommended to wait at least 2 weeks before measuring iron parameters for an accurate assessment 5

Serum ferritin is the preferred initial diagnostic test for iron overload, according to the American Association for the Study of Liver Diseases 6, 7
Transferrin saturation should be measured alongside ferritin for a comprehensive iron status assessment, as suggested by the National Kidney Foundation 5
For patients undergoing therapeutic phlebotomy, serum ferritin analysis should be performed after every 10-12 phlebotomies, approximately every 3 months, in the initial stages of treatment 6, 7

During initial treatment with phlebotomy, ferritin should be monitored every 3 months, as recommended by the American Association for the Study of Liver Diseases 6, 7
As the target ferritin range is approached, testing may be performed more frequently to avoid iron deficiency 6, 7
After achieving target ferritin levels, individualized maintenance monitoring is needed based on the rate of iron reaccumulation 6

For transfusion-dependent patients, serum ferritin should be assessed every 3 months, according to the American Society of Hematology 1, 2, 3
Organ function should be monitored periodically alongside iron studies, as recommended by the American Society of Hematology 1, 2
Consider MRI techniques for periodic monitoring of tissue iron when available, as suggested by the American Society of Hematology 1, 2

For CKD patients on erythropoietin therapy, iron status should be checked at least every 3 months, according to the National Kidney Foundation 5, 4
Monthly monitoring is recommended during initiation or dose increases of erythropoietin, as suggested by the National Kidney Foundation and the American Gastroenterological Association 5, 4
For patients receiving IV iron, wait at least 2 weeks before measuring iron parameters, as recommended by the National Kidney Foundation 5

Iron chelation therapy should be initiated when serum ferritin levels reach 1,000 ng/mL, as recommended by the American Society of Hematology 1, 2, 3
In patients with ferritin levels >1,000 ng/mL, therapeutic phlebotomy should be considered to reduce iron overload, according to the American Gastroenterological Association 4
Target ferritin levels of 50-100 μg/L indicate adequate iron depletion in hereditary hemochromatosis, as recommended by the American Association for the Study of Liver Diseases 6, 7

Patients with hyperferritinemia should be monitored annually for liver disease, as recommended by the American Gastroenterological Association 4
Patients with hereditary hemochromatosis should undergo surveillance for hepatocellular carcinoma beginning at age 50 years, according to the American Association for the Study of Liver Diseases and the American Gastroenterological Association 6, 4
Consider screening for diabetes, cardiac abnormalities, and other end-organ damage in patients with persistent hyperferritinemia, as suggested by the American Association for the Study of Liver Diseases and the American Gastroenterological Association 6, 4